S&P 및 Nasdaq 내재가치 문의하기

Deciphera Pharmaceuticals, Inc. DCPH NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$26.32
+2.9%

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Deciphera Pharmaceuticals, Inc. (DCPH), 포함 27 건 매수22 건 매도. 내부자 매수 총액은 $12.24M 내부자 매도 총액은 $1.51M.

최근 활동이 있는 주요 내부자에는 Brightstar Associates Llc, Sherman Matthew L, Kelly Thomas Patrick. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — DCPH

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2024-04-22 Brightstar Associates Llc 10 Percent Owner 옵션 행사 (ITM) 48,136 $0.01 $481.36 -
2024-02-16 Sherman Matthew L EVP & Chief Medical Officer 정보 매도 2,615 $15.62 $40.84K 108,739
2024-02-16 Kelly Thomas Patrick Chief Financial Officer 정보 매도 3,010 $15.62 $47.01K 80,350
2024-02-16 Martin Daniel C. Chief Commercial Officer 정보 매도 2,267 $15.62 $35.41K 55,118
2024-02-16 Pitman Jama SVP, Chief Development Officer 정보 매도 2,267 $15.62 $35.41K 68,031
2024-02-15 Sherman Matthew L EVP & Chief Medical Officer RSU 부여 69,100 $15.92 $1.1M 69,100
2024-02-15 Kelly Thomas Patrick Chief Financial Officer RSU 부여 69,100 $15.92 $1.1M 69,100
2024-02-15 Hoerter Steven L. President and CEO RSU 부여 298,100 $15.92 $4.75M 298,100
2024-02-15 Martin Daniel C. Chief Commercial Officer RSU 부여 38,900 $15.92 $619.29K 38,900
2024-02-15 Dhanak Dashyant EVP & Chief Scientific Officer RSU 부여 69,100 $15.92 $1.1M 69,100
2024-02-15 Pitman Jama SVP, Chief Development Officer RSU 부여 38,900 $15.92 $619.29K 38,900
2024-02-07 Brightstar Associates Llc 10 Percent Owner 옵션 행사 (ITM) 914,001 $0.01 $9.14K 48,136
2024-01-16 Sherman Matthew L EVP & Chief Medical Officer 정보 매도 2,435 $14.47 $35.23K 94,079
2024-01-16 Allen Patricia L Director RSU 부여 4,727 $14.46 $68.35K 4,727
2024-01-16 Kelly Thomas Patrick Chief Financial Officer 정보 매도 2,435 $14.47 $35.23K 66,085
2024-01-16 Squarer Ron Director RSU 부여 4,727 $14.46 $68.35K 4,727
2024-01-16 Walsh Dennis Leo Director RSU 부여 4,727 $14.46 $68.35K 4,727
2024-01-16 Martin Daniel C. Chief Commercial Officer 정보 매도 1,624 $14.47 $23.5K 47,660
2024-01-16 Friedman Franklin Stuart Director RSU 부여 4,727 $14.46 $68.35K 4,727
2024-01-16 Pitman Jama SVP, Chief Development Officer 정보 매도 1,624 $14.47 $23.5K 50,573
2023-12-13 Sherman Matthew L EVP & Chief Medical Officer 정보 매도 2,792 $15.37 $42.9K 96,514
2023-12-13 Kelly Thomas Patrick Chief Financial Officer 정보 매도 2,792 $15.37 $42.9K 68,520
2023-12-13 Hoerter Steven L. President and CEO 정보 매도 30,664 $15.37 $471.22K 72,763
2023-12-13 Martin Daniel C. Chief Commercial Officer 정보 매도 1,727 $15.37 $26.54K 49,284
2023-12-13 Pitman Jama See Remarks 정보 매도 1,662 $15.37 $25.54K 52,197
2023-12-12 Sherman Matthew L EVP & Chief Medical Officer RSU 부여 8,244 - - 99,306
2023-12-12 Kelly Thomas Patrick Chief Financial Officer RSU 부여 8,244 - - 71,312
2023-12-12 Hoerter Steven L. President and CEO RSU 부여 62,500 - - 103,427
2023-12-12 Martin Daniel C. Chief Commercial Officer RSU 부여 5,576 - - 51,011
2023-12-12 Pitman Jama See Remarks RSU 부여 5,576 - - 53,859
2023-11-30 Martin Daniel C. Chief Commercial Officer 정보 매도 17,801 $12.57 $223.76K 45,435
2023-10-30 Sherman Matthew L EVP & Chief Medical Officer 정보 매도 2,360 $12.02 $28.36K 90,628
2023-10-30 Kelly Thomas Patrick Chief Financial Officer 정보 매도 2,316 $12.02 $27.83K 63,068
2023-10-30 Hoerter Steven L. President and CEO 정보 매도 21,573 $12.02 $259.26K 40,927
2023-10-30 Martin Daniel C. Chief Commercial Officer 정보 매도 1,407 $12.02 $16.91K 62,884
2023-10-30 Pitman Jama See Remarks 정보 매도 1,407 $12.02 $16.91K 48,283
2023-10-28 Sherman Matthew L EVP & Chief Medical Officer RSU 부여 8,244 - - 92,988
2023-10-28 Kelly Thomas Patrick Chief Financial Officer RSU 부여 8,244 - - 65,384
2023-10-28 Hoerter Steven L. President and CEO RSU 부여 62,500 - - 62,500
2023-10-28 Martin Daniel C. Chief Commercial Officer RSU 부여 5,576 - - 64,291
2023-10-28 Pitman Jama See Remarks RSU 부여 5,576 - - 49,690
2023-10-02 Sherman Matthew L EVP & Chief Medical Officer 정보 매도 2,942 $12.68 $37.3K 84,744
2023-09-15 Dhanak Dashyant EVP & Chief Scientific Officer RSU 부여 65,900 - - 65,900
2023-09-05 Dhanak Dashyant Officer 알 수 없음 - - - -
2023-06-21 Allen Patricia L Director RSU 부여 30,000 $14.91 $447.3K 30,000
2023-06-21 Squarer Ron Director RSU 부여 30,000 $14.91 $447.3K 30,000
2023-06-21 Kelley Susan L. Director RSU 부여 30,000 $14.91 $447.3K 30,000
2023-06-21 Benz Edward J. Jr Director RSU 부여 30,000 $14.91 $447.3K 30,000
2023-06-21 Walsh Dennis Leo Director RSU 부여 30,000 $14.91 $447.3K 30,000
2023-06-21 Martin John Richard Director RSU 부여 30,000 $14.91 $447.3K 30,000
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기